Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Utica-Rome, NY MSA — September 2026
Metro flat, specialty roles tight — Validation Engineer pay surges.
Utica-Rome employment held flat at 122,700 jobs and unemployment ticked up to 4.3%, yet Validation Engineer pay jumped to a $131,645 metro median versus $108,377 nationally.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro unemployment rate: 4.3% — Up from 4.2% a year earlier (Aug 2026)
- Metro nonfarm employment: 122,700 jobs — Unchanged year-over-year through August 2026
- NY pharma/biotech employment: 23,643 jobs — Record high despite 39% drop in BioSpace postings
- Metro avg weekly wage: $1,218 — vs $1,654 national average, Q1 2026
Key takeaways
Validation Engineer pay is outrunning the metro's own wage trend.
Advertised pay for Validation Engineers climbed sharply to a metro median of $131,645, well above the $108,377 national figure, even as broader metro weekly wages sit roughly 26% below the national average. This divergence suggests manufacturing and quality-adjacent specialties are commanding scarcity premiums locally that general compensation benchmarking may understate.
Regulatory Affairs pay is softening even as the role stays strategically critical.
Metro Regulatory Affairs Specialist pay moved down moderately to $104,000, matching the stable national figure, despite national commentary describing regulatory talent as a global bottleneck and VP-level regulatory compensation reaching $320K-$580K. Entry-to-mid regulatory pay softening while senior regulatory pay accelerates nationally may indicate a bifurcating market worth tracking separately by seniority band.
Flat metro job count masks a selective hiring posture, not a retreat.
Utica-Rome nonfarm employment was unchanged at 122,700 jobs over the year, mirroring the statewide pattern where BioSpace postings fell 39% year-over-year despite New York pharma/biotech employment reaching a record 23,643 jobs. Leaders should read local flatness as employer selectivity rather than declining demand for specialized Life Sci talent.
Clinical Research Associate pay strength signals where real competition is concentrated.
CRA pay rose significantly both locally ($97,647) and nationally ($90,956), outpacing most other tracked roles this month. Sustained CRA wage growth amid a generally soft metro labor market suggests clinical operations talent remains genuinely scarce, independent of broader economic softening.
Median advertised pay by role — Utica-Rome, NY MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $96,431 | $131,354 | $149,743 | Stable | $131,354 |
| Clinical Research Associate | $73,450 | $97,647 | $102,251 | Significant increase | $90,956 |
| Lab Technician | $44,720 | $48,380 | $57,491 | Stable | $47,402 |
| Regulatory Affairs Specialist | $72,028 | $104,000 | $117,338 | Moderate decline | $104,000 |
| Clinical Data Manager | $103,497 | $130,206 | $146,247 | Stable | $123,031 |
| Biostatistician | $108,831 | $152,000 | $179,478 | Moderate decline | $133,322 |
| Validation Engineer | $93,667 | $131,645 | $169,080 | Significant increase | $108,377 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Utica-Rome's nonfarm employment held flat at 122,700 jobs through August 2026 while the metro unemployment rate drifted up to 4.3% from 4.2% a year earlier, with losses concentrated in professional/business services and manufacturing offsetting modest gains in private education and health services. Regional softness tracks a broader New York pattern of selective hiring — BioSpace postings statewide are down 39% year-over-year even as pharma/biotech employment hit a record 23,643 jobs, signaling employers are filling fewer but more targeted roles rather than retreating from the sector.
What it means
Flat metro headcount combined with statewide pharma/biotech employment at a record high suggests local Life Sci employers are not shrinking but are being more surgical about where they add capacity — likely concentrating hires in quality, regulatory, and specialized manufacturing/CMC functions rather than broad-based R&D expansion. Validation Engineer pay rising sharply locally (up significantly against a national pattern of moderate growth) points to manufacturing-adjacent and quality roles absorbing disproportionate wage pressure even as overall metro wages trail the national average by more than $400/week. Organizations should evaluate whether build-vs-outsource tradeoffs for CMC and manufacturing scale-up still favor internal hires at current premiums, or whether CDMO partnerships offer better cost control given the metro's below-national wage base but tightening specialty talent pool.
Looking ahead
Emerging pressure point: Metro professional/business services lost 300 jobs in the latest month alongside manufacturing and construction declines. Watch whether any of this displaced talent includes transferable regulatory, quality, or data management skills that could ease specialty hiring pressure.
Worth watching: Statewide BioSpace postings down 39% year-over-year alongside a record 23,643 pharma/biotech jobs suggests employers are backfilling selectively rather than expanding headcount broadly. Track whether Utica-area employers follow this pattern or diverge given the metro's below-national wage base.
Potential inflection point: National GLP-1 pipeline expansion is pushing manufacturing and quality hiring toward contract specialists over direct hires. Metro employers evaluating CDMO partnerships should monitor whether this national dynamic reaches upstate New York capacity decisions in the next two quarters.
Early indicator: Metro unemployment has risen for three consecutive reported months (4.1% to 4.3% year-over-year through August). Continued upward drift alongside flat nonfarm employment may loosen the local labor pool for support and administrative functions even as specialized scientific roles stay tight.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.